The small LDL-P/medium HDL-P ratio serves as an exploratory, hypothesis-generating biomarker for detecting subclinical atherosclerosis in severe obesity that requires validation in larger cohorts.
This editorial response clarifies that the small LDL-P/medium HDL-P ratio is an exploratory biomarker for subclinical atherosclerosis in severe obesity that requires validation in larger, adequately powered cohorts.
Carmona-Maurici et al. (Wed,) conducted a letter in Severe obesity and subclinical atherosclerosis. small LDL-P/medium HDL-P ratio was evaluated. The small LDL-P/medium HDL-P ratio serves as an exploratory, hypothesis-generating biomarker for detecting subclinical atherosclerosis in severe obesity that requires validation in larger cohorts.